Sandy Spring Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20
Closed -$11K 1153
2022
Q1
$11K Hold
20
﹤0.01% 836
2021
Q4
$13K Hold
20
﹤0.01% 853
2021
Q3
$12K Hold
20
﹤0.01% 841
2021
Q2
$13K Hold
20
﹤0.01% 852
2021
Q1
$10K Buy
+20
New +$10K ﹤0.01% 794
2018
Q4
Sell
-6
Closed -$1K 782
2018
Q3
$1K Hold
6
﹤0.01% 761
2018
Q2
$1K Hold
6
﹤0.01% 750
2018
Q1
$1K Buy
+6
New +$1.11K ﹤0.01% 816
2017
Q1
Sell
-26
Closed -$3K 851
2016
Q4
$3K Hold
26
﹤0.01% 795
2016
Q3
$3K Sell
26
-60
-70% -$6.32K ﹤0.01% 778
2016
Q2
$8K Hold
86
﹤0.01% 703
2016
Q1
$7K Hold
86
﹤0.01% 744
2015
Q4
$6K Buy
86
+26
+43% +$1.85K ﹤0.01% 747
2015
Q3
$4K Hold
60
﹤0.01% 804
2015
Q2
$4K Buy
+60
New +$4.15K ﹤0.01% 833

Other funds holding IDXX

Sandy Spring Bank's IDXX Position: Q2 2022 in Review

Sandy Spring Bank sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 20 shares — an estimated $11K sold.

Sandy Spring Bank first reported a position in IDXX in Q2 2015 and held it in 15 quarters. The position peaked at $13K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Sandy Spring Bank reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Sandy Spring Bank sold 20 Idexx Laboratories shares in Q2 2022, an estimated $11K.
  • Sandy Spring Bank first reported a position in Idexx Laboratories in Q2 2015 and held it in 15 quarters.
  • Sandy Spring Bank's Idexx Laboratories position peaked at $13K in Q4 2021.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Sandy Spring Bank's 13F filing for Q2 2022, filed 21 Jul 2022.